In a draft guidance published Friday, the US Food and Drug Administration (FDA) says it does not intend to take action against manufacturers who do not affix or imprint a product identifier to each ...
Industry groups and drugmakers are calling for changes to the US Food and Drug Administration’s (FDA) recent draft questions and answers guidance on product identifiers under the Drug Supply Chain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results